Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 191

Results For "NITI"

3240 News Found

Mandaviya addresses the G7 Health Ministerial Meeting on health innovation
Policy | May 16, 2023

Mandaviya addresses the G7 Health Ministerial Meeting on health innovation

The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries


Mandaviya addresses the G7 Ministerial Meeting on global health architecture
Policy | May 16, 2023

Mandaviya addresses the G7 Ministerial Meeting on global health architecture

Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security


Briefs: Dr. Reddy's Laboratories and Max Healthcare Institute
News | May 15, 2023

Briefs: Dr. Reddy's Laboratories and Max Healthcare Institute

Dr. Reddy's Laboratories has been issued a Form 483 with four observations


Sanofi India to demerge healthcare businesses
News | May 12, 2023

Sanofi India to demerge healthcare businesses

This decision will accelerate growth for both its pharma & consumer healthcare businesses in India


Lilly allocates additional US $50 million to Social Impact Venture Capital portfolio
News | May 12, 2023

Lilly allocates additional US $50 million to Social Impact Venture Capital portfolio

The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries


Gilead acquires XinThera to strengthen pipeline in oncology
News | May 12, 2023

Gilead acquires XinThera to strengthen pipeline in oncology

Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors


AIIA and CCRAS jointly organised session for research and education in Ayush
News | May 11, 2023

AIIA and CCRAS jointly organised session for research and education in Ayush

Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc


Venus Remedies bolsters its position in oncology space with marketing approval from Philippines, Iraq
Drug Approval | May 10, 2023

Venus Remedies bolsters its position in oncology space with marketing approval from Philippines, Iraq

The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region


Boehringer Ingelheim begins clinical development for fibrotic diseases
News | May 10, 2023

Boehringer Ingelheim begins clinical development for fibrotic diseases

‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,


Baxter  to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion
News | May 09, 2023

Baxter to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion

Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation